Developer docs
API playgroundTry for free, no card

Search company profiles

Regenesis

Full company profile

uuid000c6ux

Namestring
Regenesis
Legal namestring
Regenesis Biomedical Inc.
Company typeenum
Private
Founded yearint
1997
Descriptiontext

Regenesis Biomedical, Inc., founded in 1997 and headquartered in Scottsdale, Arizona, is a privately held medical device manufacturer focused on non-drug pain relief. Its core product line is the Reprieve family of electromagnetic shortwave diathermy devices, which expose tissue to electromagnetic energy intended to produce an analgesic effect. The portfolio includes the base Reprieve unit plus variants (Reprieve-60, Reprieve-60 Duo, Reprieve Duo) configured with single or dual treatment pads, alongside supporting instructional materials such as pad positioning guides and instruction manuals. The devices are FDA-cleared and approved for home use, enabling patient self-treatment with twice-daily sessions and no required disposables.

The company's commercial model is anchored in federal healthcare procurement rather than direct-to-consumer sales. Reprieve is provided at no cost to eligible Veterans Administration (VA) health care beneficiaries, with revenue originating from government procurement — including distribution through the GSA Advantage marketplace under contract 36F79725D0002 — and supported by dedicated Patient Care Coordinators providing VA-centric treatment support. The company reports clinical adoption metrics of 30,000+ patients treated, 24,000+ veterans treated through the VA, 5+ million treatments delivered, and a 95% patient satisfaction rate, with targeted indications including diabetic neuropathy, plantar fasciitis, lumbar back pain, and osteoarthritis. Regenesis is also expanding beyond the VA through a specialized Pain Relief for Native Communities program.

The company is privately held with 101–250 employees, operates a single-country (USA) geographic footprint, and earns the U.S. Department of Labor HIRE Vets Gold Award in 2025 for veteran-focused hiring practices. Marketing is executed primarily through organic social channels (Facebook, LinkedIn, YouTube) for top-of-funnel awareness. No parent company, institutional investors, funding rounds, or material M&A activity are disclosed in the available data.

Short descriptiontext

Regenesis Biomedical is a Scottsdale, Arizona-based medical device manufacturer that produces the Reprieve line of FDA-cleared electromagnetic shortwave diathermy devices for non-drug, at-home pain relief, distributing them to U.S. veterans at no cost via Veterans Administration federal procurement and expanding into Native Community programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersScottsdale, United States
HQ citystring
Scottsdale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
shortwave diathermy devices, non-drug pain management, home-use medical devices, electromagnetic therapy systems, veterans healthcare devices
Industry1 code
PRIMARYHSADAIAJ
Chronic Pain Rehabilitation & Functional Restoration
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Pain Management Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Distribution to VA Healthcare
TypeHardware Sales
Description

Reprieve devices are provided at no cost to Veterans Administration health care beneficiaries, suggesting a model where the company supplies devices to VA healthcare facilities at no cost to patients. Revenue appears to come from government healthcare system procurement rather than direct patient sales.

regenesismed.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1VA Healthcare Program - No cost to eligible Veterans
ModelOtherBilling cadenceOther
Notes

Available at no cost to VA health care beneficiaries. No direct patient pricing.

regenesismed.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Reprieve
Description

Shortwave diathermy medical device for safe, non-drug pain relief. Patients can self-treat at home. Available at no cost to Veterans Administration (VA) health care beneficiaries.

regenesismed.com
Core offering1 text field

Regenesis manufactures and distributes the Reprieve line of electromagnetic shortwave diathermy medical devices for non-drug pain relief. Devices are FDA-cleared for home use, enabling patients to self-treat chronic pain conditions (diabetic neuropathy, plantar fasciitis, back pain, osteoarthritis) through twice-daily electromagnetic therapy sessions. The primary distribution channel is the Veterans Administration healthcare system, where Reprieve devices are provided at no cost to eligible VA health care beneficiaries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 30,000 patients treated with proven clinical outcomes
+2 more records
Product overview1 text field

Regenesis offers a focused portfolio of medical devices centered on its Reprieve line of electromagnetic shortwave diathermy therapy products. The core Reprieve device and its variants (Reprieve-60, Reprieve-60 Duo, Reprieve Duo) deliver non-drug pain management for home use. The company primarily serves the Veterans Administration healthcare system, providing devices at no cost to eligible veterans. Treatment protocols target common pain conditions including diabetic neuropathy, plantar fasciitis, lumbar back pain, and osteoarthritis, with supporting instructional materials including pad positioning guides and user manuals.

Product and service4 records
1Reprieve by Regenesis
2Reprieve-60
CategoryPain Management Medical Device (Variant)
Description

Shortwave diathermy device model variant with standard energy settings based on research, intended to provide an analgesic effect for non-drug pain relief.

3Reprieve-60 Duo
CategoryPain Management Medical Device (Variant)
Description

Dual-pad shortwave diathermy device model for expanded treatment coverage and broader tissue treatment area.

4Reprieve Duo
CategoryPain Management Medical Device (Variant)
Description

Dual treatment pad configuration shortwave diathermy device providing broader tissue treatment area for non-drug pain relief.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Regenesis

Pain Management Medical Devicesregenesismed.com

Regenesis Biomedical is a Scottsdale, Arizona-based medical device manufacturer that produces the Reprieve line of FDA-cleared electromagnetic shortwave diathermy devices for non-drug, at-home pain relief, distributing them to U.S. veterans at no cost via Veterans Administration federal procurement and expanding into Native Community programs.

What Regenesis does

Regenesis Biomedical, Inc., founded in 1997 and headquartered in Scottsdale, Arizona, is a privately held medical device manufacturer focused on non-drug pain relief. Its core product line is the Reprieve family of electromagnetic shortwave diathermy devices, which expose tissue to electromagnetic energy intended to produce an analgesic effect. The portfolio includes the base Reprieve unit plus variants (Reprieve-60, Reprieve-60 Duo, Reprieve Duo) configured with single or dual treatment pads, alongside supporting instructional materials such as pad positioning guides and instruction manuals. The devices are FDA-cleared and approved for home use, enabling patient self-treatment with twice-daily sessions and no required disposables.

The company's commercial model is anchored in federal healthcare procurement rather than direct-to-consumer sales. Reprieve is provided at no cost to eligible Veterans Administration (VA) health care beneficiaries, with revenue originating from government procurement — including distribution through the GSA Advantage marketplace under contract 36F79725D0002 — and supported by dedicated Patient Care Coordinators providing VA-centric treatment support. The company reports clinical adoption metrics of 30,000+ patients treated, 24,000+ veterans treated through the VA, 5+ million treatments delivered, and a 95% patient satisfaction rate, with targeted indications including diabetic neuropathy, plantar fasciitis, lumbar back pain, and osteoarthritis. Regenesis is also expanding beyond the VA through a specialized Pain Relief for Native Communities program.

The company is privately held with 101–250 employees, operates a single-country (USA) geographic footprint, and earns the U.S. Department of Labor HIRE Vets Gold Award in 2025 for veteran-focused hiring practices. Marketing is executed primarily through organic social channels (Facebook, LinkedIn, YouTube) for top-of-funnel awareness. No parent company, institutional investors, funding rounds, or material M&A activity are disclosed in the available data.

Regenesis firmographics

Firmographics
Name
Regenesis
Legal name
Regenesis Biomedical Inc.
Website
https://regenesismed.com
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
101–250 employees
Short description
Regenesis Biomedical is a Scottsdale, Arizona-based medical device manufacturer that produces the Reprieve line of FDA-cleared electromagnetic shortwave diathermy devices for non-drug, at-home pain relief, distributing them to U.S. veterans at no cost via Veterans Administration federal procurement and expanding into Native Community programs.
Ownership category
akta.pro rank

Regenesis industry classification

Industry
Product category
Pain Management Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHSADAIAJ
Chronic Pain Rehabilitation & Functional Restoration
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise

Keywords

  • Shortwave diathermy devices
  • Non-drug pain management
  • Home-use medical devices
  • Electromagnetic therapy systems
  • Veterans healthcare devices

Where Regenesis is headquartered

Location

Headquarters

HQ city
Scottsdale
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Regenesis business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Medical Device Distribution to VA Healthcare: Reprieve devices are provided at no cost to Veterans Administration health care beneficiaries, suggesting a model where the company supplies devices to VA healthcare facilities at no cost to patients. Revenue appears to come from government healthcare system procurement rather than direct patient sales.

Pricing tiers

ModelBillingPrice
OtherOtherVA Healthcare Program - No cost to eligible Veterans

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Regenesis product offering

Product offering

Core offering

Regenesis manufactures and distributes the Reprieve line of electromagnetic shortwave diathermy medical devices for non-drug pain relief. Devices are FDA-cleared for home use, enabling patients to self-treat chronic pain conditions (diabetic neuropathy, plantar fasciitis, back pain, osteoarthritis) through twice-daily electromagnetic therapy sessions. The primary distribution channel is the Veterans Administration healthcare system, where Reprieve devices are provided at no cost to eligible VA health care beneficiaries.

Product overview

Regenesis offers a focused portfolio of medical devices centered on its Reprieve line of electromagnetic shortwave diathermy therapy products. The core Reprieve device and its variants (Reprieve-60, Reprieve-60 Duo, Reprieve Duo) deliver non-drug pain management for home use. The company primarily serves the Veterans Administration healthcare system, providing devices at no cost to eligible veterans. Treatment protocols target common pain conditions including diabetic neuropathy, plantar fasciitis, lumbar back pain, and osteoarthritis, with supporting instructional materials including pad positioning guides and user manuals.

Differentiator

Problem solved

Functional benefit

Brands

  • Reprieve: Shortwave diathermy medical device for safe, non-drug pain relief. Patients can self-treat at home. Available at no cost to Veterans Administration (VA) health care beneficiaries.

Products and services

  • Reprieve by Regenesis
  • Reprieve-60 Shortwave diathermy device model variant with standard energy settings based on research, intended to provide an analgesic effect for non-drug pain relief.
  • Reprieve-60 Duo Dual-pad shortwave diathermy device model for expanded treatment coverage and broader tissue treatment area.
  • Reprieve Duo Dual treatment pad configuration shortwave diathermy device providing broader tissue treatment area for non-drug pain relief.

Quantifiable outcome

  • Over 30,000 patients treated with proven clinical outcomes
  • +2 more outcomes

Companies that use Regenesis

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Regenesis technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Regenesis partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Regenesis competitors and assessment

Company assessment

Market position

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Regenesis social profiles

Digital presence

Regenesis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Regenesis leadership team

Management profile

Number of profiles

Regenesis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Regenesis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regenesis

What does Regenesis do?

Regenesis manufactures and distributes the Reprieve line of electromagnetic shortwave diathermy medical devices for non-drug pain relief. Devices are FDA-cleared for home use, enabling patients to self-treat chronic pain conditions (diabetic neuropathy, plantar fasciitis, back pain, osteoarthritis) through twice-daily electromagnetic therapy sessions. The primary distribution channel is the Veterans Administration healthcare system, where Reprieve devices are provided at no cost to eligible VA health care beneficiaries.

Is Regenesis a public or private company?

Regenesis is a private company. It is classified as unknown and is currently operating.

When was Regenesis founded?

Regenesis was founded in 1997. It employs 101 to 250 people.

Where is Regenesis based?

Regenesis is headquartered in Scottsdale, United States, in the North America region.

How does Regenesis make money?

One revenue line is on record: medical Device Distribution to VA Healthcare.

Does Regenesis have an API?

No public API is recorded for Regenesis.

What industry is Regenesis in?

Regenesis's product category is Pain Management Medical Devices. Its primary akta.pro industry code is HSADAIAJ, Chronic Pain Rehabilitation & Functional Restoration. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales